Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2002
10/03/2002CA2441393A1 Therapeutic compositions that alter the immune response
10/03/2002CA2441378A1 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002CA2441377A1 Protein phosphate inhibitors
10/03/2002CA2441228A1 Combination treatment of pancreatic cancer
10/03/2002CA2441227A1 Liposome targeting of matrix metalloproteinase inhibitors
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2440322A1 Oligonucleotide conjugates
10/03/2002CA2439676A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/03/2002CA2439630A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/03/2002CA2439409A1 Inhibitors of glycosaminoglycans
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/03/2002CA2436224A1 Cytotoxic factors for modulating cell death
10/03/2002CA2436198A1 Process for obtaining lignan, pharmaceutical compositions and uses thereof
10/03/2002CA2434020A1 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002CA2425862A1 Cd19-specific redirected immune cells
10/03/2002CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same
10/03/2002CA2405453A1 Pharmaceutical composition containing camptothecin derivative and ph-adjusting substance
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1245565A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
10/02/2002EP1245562A1 5-THIA-$g(v)-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
10/02/2002EP1245235A2 Method for extracting oleaginous substances from ganoderma lucidum spores
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244915A2 Method for identifying inhibitors of cytokinesis
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244805A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes
10/02/2002EP1244798A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244786A1 Screening method for compounds capable of modularing egr-1-regulated expression
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002EP1244778A2 Human heparanase-related polypeptide and nucleic acid
10/02/2002EP1244774A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/02/2002EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244698A2 Novel human transporter proteins and polynucleotides encoding the same
10/02/2002EP1244695A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244679A1 Purine derivatives
10/02/2002EP1244678A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244677A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002EP1244668A1 Purine derivatives, process for their preparation and use thereof
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244652A1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
10/02/2002EP1244651A1 Diamidine compounds as dna minor groove binders
10/02/2002EP1244650A1 Arylamine derivatives and their use as anti-telomerase agent
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244647A1 Quinazoline derivatives as vegf inhibitors
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244624A1 Anthracene derivatives as anti-cancer agents
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244617A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
10/02/2002EP1244471A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
10/02/2002EP1244469A2 Mutant simplex virus for treating unwanted hyperproliferative cell growth
10/02/2002EP1244466A2 Activation and inhibition of the immune system
10/02/2002EP1244462A2 Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244454A2 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
10/02/2002EP1244445A2 Use of azoles for preventing skin cancer
10/02/2002EP1244443A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
10/02/2002EP1244440A1 Agonists specific for the peripheral cannabinoid receptor
10/02/2002EP1244435A2 POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND $g(a)-SYNUCLEIN FIBRIL DISEASES
10/02/2002EP1244432A2 Methods for pulmonary delivery of interleukin-2
10/02/2002EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
10/02/2002EP1244350A2 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal
10/02/2002EP1077964B1 Fumagillol derivatives and processes for preparing the same
10/02/2002EP1077068B9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
10/02/2002EP0960107B1 6-thio-substituted paclitaxels
10/02/2002EP0841924B1 Benzimidazole compounds
10/02/2002EP0788356B9 Method and compositions for inhibiting protein kinases
10/02/2002EP0717750B1 Double-stranded peptide nucleic acids
10/02/2002EP0715628B1 Substituted azaindolylidene compounds and process for their preparation
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002EP0691988B1 Inhibitor of stem cell proliferation and uses thereof
10/02/2002EP0668933B1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
10/02/2002EP0651636B1 Chemotherapy for cancer
10/02/2002DE10115740A1 Zubereitung für die Restenoseprophylaxe Preparation for the prophylaxis of restenosis
10/02/2002DE10114138A1 Cdk-inhibitorische Indirubinderivate mit erhöhter Löslichkeit Cdk-inhibitory indirubin derivatives with increased solubility
10/02/2002DE10112926A1 Use of sugar phosphate or aminoacid having e.g. transaminase inhibiting activity, for treating tumors and/or sepsis or inducing immunosuppression
10/02/2002DE10112924A1 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate 1-butanoic acid derivatives, pharmaceutical compositions containing such derivatives and uses of such derivatives
10/02/2002DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002DE10111682A1 Caloporosid-Derivate, Verfahren zu deren Herstellung und deren Verwendung Caloporoside derivatives, processes for their preparation and their use
10/02/2002CN1372598A Methods of inducing cell death
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them
10/02/2002CN1372556A Heterocyclic compound inhibiting angiogenesis
10/02/2002CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002CN1372474A Methods for preventing or attenuating patthoangiogenic conditions
10/02/2002CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/02/2002CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002CN1372466A New use of docetaxel for treating hepatoma
10/02/2002CN1371916A Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use
10/02/2002CN1371915A Novel human cell endocytic regulatory protein, its coding sequence and use
1 ... 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 ... 2211